Abstract
Despite great reduction of in-stent restenosis, first-generation drug-eluting stents (DESs) have increased the risk of late stent thrombosis due to delayed endothelialization. Arsenic trioxide, a natural substance that could inhibit cell proliferation and induce cell apoptosis, seems to be a promising surrogate of sirolimus to improve DES performance. This randomized controlled trial was to evaluate the efficacy and safety of a novel arsenic trioxide-eluting stent (AES), compared with traditional sirolimus-eluting stent (SES). Patients with symptoms of angina pectoris were enrolled and randomized to AES or SES group. The primary endpoint was target vessel failure (TVF), and the second endpoint includes rates of all-cause death, cardiac death or myocardial infarction, target lesion revascularization (TLR) by telephone visit and late luminal loss (LLL) at 9-month by angiographic follow-up. From July 2007 to 2009, 212 patients were enrolled and randomized 1:1 to receive either AES or SES. At 2 years of follow-up, TVF rate was similar between AES and SES group (6.67% vs. 5.83%, P = 0.980). Frequency of all-cause death was significantly lower in AES group (0 vs. 4.85%, P = 0.028). There was no significant difference between AES and ...Continue Reading
References
Sep 18, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L SoignetR P Warrell
Jan 28, 2004·Circulation·Renu VirmaniFrank D Kolodgie
Jul 4, 2006·Journal of the American College of Cardiology·Michael JonerRenu Virmani
Oct 6, 2006·Cardiovascular Research·Wei YangYunzeng Zou
May 19, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Aloke V FinnRenu Virmani
Jul 9, 2008·Journal of Cardiovascular Medicine·Imad SheibanAntonio L Bartorelli
Jul 26, 2008·Journal of the American College of Cardiology·Michael JonerRenu Virmani
May 14, 2009·Molecular Biology Reports·Jing-Xiu LiXue-Qi Li
Mar 3, 2010·Nature Reviews. Cardiology·Rainer Wessely
Mar 10, 2010·American Heart Journal·Kyung Woo ParkHyo-Soo Kim
Jan 5, 2011·Heart·Kenichi FujiiTohru Masuyama
Mar 27, 2012·European Heart Journal·Giulio G StefaniniAdnan Kastrati
Mar 31, 2012·International Journal of Cardiology·Yoshiyasu MinamiToshiaki Nakajima
May 23, 2012·Nature Reviews. Cardiology·Fumiyuki OtsukaRenu Virmani
Mar 26, 2013·JACC. Cardiovascular Interventions·Ajay J KirtaneUNKNOWN ENDEAVOR IV Investigators
Apr 23, 2013·JACC. Cardiovascular Interventions·David E KandzariLaura Mauri
May 25, 2013·JACC. Cardiovascular Interventions·Michael A Kutcher
Citations
Dec 17, 2017·Circulation·Feng YangQingzhong Xiao
Feb 1, 2018·Medicine·Pravesh Kumar BundhunFeng Huang
Apr 18, 2017·Experimental and Therapeutic Medicine·Shasha ZhangZhifeng Li
Sep 22, 2020·Bioactive Materials·Yinping ZhaoGuixue Wang